Fever in Childhood Infectious Mononucleosis

Authors

  • Elda Skenderi University Hospital Center “Mother Teresa”, Tirana, Albania
  • Gjeorgjina Kuli-Lito University Hospital Center "Mother Tereza", Tirana, Albania
  • Alberta Shkembi University Hospital Center "Mother Tereza", Tirana, Albania
  • Nilsa Shahini University Hospital Center "Mother Tereza", Tirana, Albania
  • Griselda Toci University Hospital Center "Mother Tereza", Tirana, Albania
  • Ada Pema University Hospital Center "Mother Tereza", Tirana, Albania

DOI:

https://doi.org/10.53555/hsn.v7i2.1497

Keywords:

Fever, Children, Infectious Mononucleosis, duration of fever, lymphocytes

Abstract

Fever is one of the oldest clinical indicators of disease and one of the most common reasons for medical attention worldwide especially in children. The febrile response is a significant contributor to the pathogenesis, clinical presentation and outcome of many diseases. Infectious Mononucleosis, which is the most common clinical manifestation caused by EBV infection, usually begins insidiously, with vague malaise, followed by fever, sore throat, swollen posterior cervical lymph nodes and fatigue. Of the 107 children with Infectious Mononucleosis enrolled in the study 97% had fever. Fever was the first symptom in 84% of those. 29% of children experienced high levels of fever >40°C. There was an association statistically significant between the duration of fever: levels of lymphocytes, levels of alanine aminotransferase, and levels of anxiety. As a conclusion it can be stated that fever is the most common symptom in children with Infectious Mononucleosis. Compared to older children, infants and young children experience higher and more prolonged fevers, more rapid temperature increases, and greater temperature fluctuations.  The duration of fever in Infectious Mononucleosis is much longer than in most other viral infections of childhood. The potent innate and adaptive immune response, which occurs during primary EBV infection controls infection and is responsible for the most symptoms and signs of the disease including fever.

Downloads

Download data is not yet available.

References

Acremont,V.D. Burnand,B. Ambresin, A. Genton, B. Practice guidelines for evaluation of fever in returning travellers and migrants J Travel Med, 10 (Suppl. 2) (2003) S25–S52 Google Scholar

Balfour, H. H., Jr., et al. 2009. Randomized, placebo-controlled, double-blind trial of valomaciclovir (VALM) for infectious mononucleosis, abstr. V1256a. Abstr. 49th Intersci. Conf. Antimicrob. Agents Chemother., San Francisco, CA. American Society for Microbiology, Washington, DC.

Balfour, H. H., Jr., et al. 2007. A virologic pilot study of valacyclovir for infectious mononucleosis. J. Clin. Virol. 39:16-21. [PubMed] [Google Scholar]

Balfour, H. H., Jr., et al. 2005. A prospective clinical study of Epstein-Barr virus and host interactions during acute infectious mononucleosis. J. Infect. Dis. 192:1505-1512. [PubMed] [Google Scholar]

Crawford, D. H., et al. 2002. Sexual history and Epstein-Barr virus infection. J. Infect. Dis. 186:731-736. [PubMed] [Google Scholar]

Dinarello CA, Gelfand JA, Fever and hyperthermia. In: Fauci AS, Kasper DL, Longo DL, Braunwald E, Hauser SL, Jameson JL, Loscalzo J, editors. Harrison's principles of internal medicine. McGraw-Hill's Company, 17th edition, 2005, p. 90–4 [chapter 17].Google Scholar

Ebrahimi, B., B. M. Dutia, D. G. Brownstein, and A. A. Nash. 2001. Murine gammaherpesvirus-68 infection causes multi-organ fibrosis and alters leukocyte trafficking in interferon-gamma receptor knockout mice. Am. J. Pathol. 158:2117-2125. [PMC free article] [PubMed] [Google Scholar]

Eichenwald, H.F. Fever and antipyresis. Bull World Health Organ, 81 (5) (2003), pp. 372-374 View Record in ScopusGoogle Scholar

Evans, A. S. 1978. Infectious mononucleosis and related syndromes. Am. J. Med. Sci. 276:325-339. [PubMed] [Google Scholar]

Ginsburg, C. M., W. Henle, G. Henle, and C. A. Horwitz. 1977. Infectious mononucleosis in children. Evaluation of Epstein-Barr virus-specific serological data. JAMA 237:781-785. [PubMed] [Google Scholar]

Graneto, J.W. Pediatrics, fever emedicine specialities, emergency medicine, paediatric Updated 20.05.10 (2010) Available at: www.emedicine.medscape.com/specialities Google Scholar

Grotto, I., et al. 2003. Clinical and laboratory presentation of EBV positive infectious mononucleosis in young adults. Epidemiol. Infect. 131:683-689. [PMC free article] [PubMed] [Google Scholar]

Hadinoto, V., et al. 2008. On the dynamics of acute EBV infection and the pathogenesis of infectious mononucleosis. Blood 111:1420-1427. [PMC free article] [PubMed] [Google Scholar]

Henke, C. E., L. T. Kurland, and L. R. Elveback. 1973. Infectious mononucleosis in Rochester, Minnesota, 1950 through 1969. Am. J. Epidemiol. 98:483-490. [PubMed] [Google Scholar]

Henle, G., W. Henle, and V. Diehl. 1968. Relation of Burkitt's tumor-associated herpes-type virus to infectious mononucleosis. Proc. Natl. Acad. Sci. U. S. A. 59:94-101. [PMC free article] [PubMed] [Google Scholar]

Hislop, A. D., G. S. Taylor, D. Sauce, and A. B. Rickinson. 2007. Cellular responses to viral infection in humans: lessons from Epstein-Barr virus. Annu. Rev. Immunol. 25:587-617. [PubMed] [Google Scholar]

Hoagland, R. J. 1960. The clinical manifestations of infectious mononucleosis: a report of two hundred cases. Am. J. Med. Sci. 240:55-63. [PubMed] [Google Scholar]

Kieff, E., and A. B. Rickinson. 2007. Epstein-Barr virus and its replication, p. 2603-2654. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. M. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 5th ed., vol. II. Lippincott Williams & Wilkins, Philadelphia, PA. [Google Scholar]

Lee, K. S., S. D. Groshong, C. D. Cool, B. K. Kleinschmidt-DeMasters, and L. F. van Dyk. 2009. Murine gammaherpesvirus 68 infection of IFNgamma unresponsive mice: a small animal model for gammaherpesvirus-associated B-cell lymphoproliferative disease. Cancer Res. 69:5481-5489. [PMC free article] [PubMed] [Google Scholar]

Leggett, J.Approach to fever or suspected infection in the normal host G. Lee, D. Ausiello (Eds.), Cecil medicine (23rd edition), Saunders Elsevier (2008), pp. 2112-2124 [chapter 302] View Record in ScopusGoogle Scholar

Leon, L.R. Cytokine regulation of fever: studies using gene knockout mice J Appl Physiol, 92 (2002), pp. 2648-2655 CrossRefView Record in ScopusGoogle Scholar

Mabey,D., Doherty, T. The febrile patient E. Parry, R. Godfrey, D. Mabey, G. Gill (Eds.), Principles of medicine in Africa (3rd edition), Cambridge University Press (2004), pp. 191-197 View Record in ScopusGoogle Scholar

Mackowiak, P.A. Temperature regulation and pathogenesis of fever(6th edition), Mandell, Douglas and Bennett's Principles and practise of infectious disease, vol. 1, Elsevier Churchill Livingstone (2005) pp. 703–718 Google Scholar

Mackowiak, P.A Fever: blessing or curse? a unifying hypothesis Ann Intern Med, 120 (1994), pp. 1037-1040 CrossRefView Record in ScopusGoogle Scholar

McKinlay, C. A. 1935. Infectious mononucleosis. I. Clinical aspects. JAMA 105:761-764. [Google Scholar]

O’Grady,N.P.O. Barie,P.S. Bartlett, J.G Bleck, T. Carroll, K.R.N. Kalil, A.C. et al.Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Diseases Society of America Crit Care Med, 36 (2008), pp. 1330-1349 View Record in ScopusGoogle Scholar

Rea, T. D., J. E. Russo, W. Katon, R. Ashley, and D. S. Buchwald. 2001. Prospective study of the natural history of infectious mononucleosis caused by Epstein-Barr virus. J. Am. Board Fam. Pract. 14:234-242. [PubMed] [Google Scholar]

Roth, J. de Souza, G.E.P. Fever induction pathways: evidence from responses to systemic or local cytokine formation Braz J Med Biol Res, 34 (3) (2001), pp. 301-314 View Record in ScopusGoogle Scholar

Schiller, J. H., et al. 1990. Biological and clinical effects of the combination of beta- and gamma-interferons administered as a 5-day continuous infusion. Cancer Res. 50:4588-4594. [PubMed] [Google Scholar]

Selin, L. K., et al. 2006. Memory of mice and men: CD8+ T-cell cross-reactivity and heterologous immunity. Immunol. Rev. 211:164-181. [PMC free article] [PubMed] [Google Scholar]

Silins, S. L., et al. 2001. Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral load. Blood 98:3739-3744. [PubMed] [Google Scholar]

Sprunt, T. P., and F. A. Evans. 1920. Mononuclear leucocytosis in reaction to acute infections (“infectious mononucleosis”). Johns Hopkins Hosp. Bull. 31:410-417. [Google Scholar]

Sumaya, C. V., W. Henle, G. Henle, M. H. Smith, and D. LeBlanc. 1975. Seroepidemiologic study of Epstein-Barr virus infections in a rural community. J. Infect. Dis. 131:403-408. [PubMed] [Google Scholar]

Tatro, J.B. Endogenous antipyretics Clin Infect Dis, 31 (2000), pp. S190-S201 View Record in ScopusGoogle Scholar

Todd, W.T.A. Lockwood, D.N.J. Nye, F.J. Wilkins, E.G.L. Carey, P.E.Infections and immune failure C. Haslett, E.R. Chilves, N.A. Boon, N.R. Colledge (Eds.), Davidson's principle and practise of medicine (19th edition), Churchill Livingstone Elsevier Limited (2002), pp. 8-115 [chapter 1] View Record in ScopusGoogle Scholar

Weck, K. E., et al. 1997. Murine gamma-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-gamma responsiveness: a new model for virus-induced vascular disease. Nat. Med. 3:1346-1353. [PubMed] [Google Scholar]

World health organization Integrated management of childhood illness (2008) Retrieved from: www.who.int. Google Scholar

World health organization Guidelines for the treatment of malaria (2006) Retrieved from: www.who.int. Google Scholar

Downloads

Published

2021-03-31

How to Cite

Skenderi, E., Kuli-Lito, G., Shkembi, A., Shahini, N., Toci, G., & Pema, A. (2021). Fever in Childhood Infectious Mononucleosis. International Journal For Research In Health Sciences And Nursing, 7(2), 16–26. https://doi.org/10.53555/hsn.v7i2.1497